Radiotherapy and Management in Maxillofacial Prosthodontic
PDF

Keywords

Radiotherapy
Prosthodontics
Team collaboration

Categories

How to Cite

1.
El Hawari W, Rokhssi H, Azhari M, Merzouk N, Bentahar O. Radiotherapy and Management in Maxillofacial Prosthodontic: Part 3 - Proposal for a Joint Sheet Between the Specialist in Maxillofacial Prosthodontics and the Radiotherapist / Oncologist. Integr J Med Sci [Internet]. 2021 Jan. 18 [cited 2022 Aug. 12];8. Available from: https://mbmj.org/index.php/ijms/article/view/388

Abstract

The effects of anticancer treatments and cancerous pathology most often lead to tissue defects, deformities and mobility limitations that significantly alter the functions of chewing, swallowing, breathing and communication. These complications are taken care of by different practioners belonging to different specialties.
The odontological care of cancer patients must be part of a multidisciplinary collaboration, indeed, it aims to plan and optimize the conduct of care in relation with the progress of anti-cancer treatment (Radiotherapy, chemotherapy, etc.).
The objective of this work is to focus on the areas of collaboration between the specialist in maxillofacial prosthosontic and the radiotherapist / oncologist and to propose a liaison sheet between these two practioners to facilitate communication and achieve a symbiosis.
This liaison sheet constitutes a tool streamlining the multidisciplinary consultation between the odontologist and the radiotherapist / oncologist and consequently facilitating the care of these patients.

https://doi.org/10.15342/ijms.2021.388
PDF

References

Jham BC, Reis PM, Miranda EL, Lopes RC, Carvalho AL, Scheper MA, et al. Oral health status of 207 head and neck cancer patients before, during and after radiotherapy. Clin Oral Investig. 2008;12(1):19-24. https://doi.org/10.1007/s00784-007-0149-5

Husein AB, Butterworth CJ, Ranka MS, KwasnickiA, Rogers SN. A Survey of General Dental Practitioners in the North West of England Concerning the Dental Care of Patients. Prim Dent Care. 2011;18(2):59-65. https://doi.org/10.1308/135576111795162910

Sennhenn-Kirchner S, Freund F, Grundmann S, Martin A, Zepelin MB, Christiansen H et al. Dental therapy before and after radiotherapy–an evaluation on patients with head and neck malignancies. Clin Oral Investig. 2009; 13(2):157 164. https://doi.org/10.1007/s00784-008-0229-1

Eid A, Li S, Garza R, Wong ME. Chemotherapy for Oral and Maxillofacial Tumors: An Update. Oral Maxillofac Surg Clin North Am. 2014 ;26(2):163-9. https://doi.org/10.1016/j.coms.2014.01.004

Song M. Dental care for patients taking antiresorptive drugs: a literature review.Restor Dent Endod.2019;44(4):e42. https://doi.org/10.5395/rde.2019.44.e42

Baron R, Ferrari S, Russell RGG. Denosumab and bisphosphonates: Different mechanisms of action and effects. 2011 ;48(4):677-92. https://doi.org/10.1016/j.bone.2010.11.020

Wehrhan F, Moebius P, Amann K, Ries J, Preidl R, Neukam FW, et al. Macrophage and osteoclast polarization in bisphosphonate associated necrosis and osteoradionecrosis. J Craniomaxillofac Surg. 2017;45(6):944-953. https://doi.org/10.1016/j.jcms.2017.02.023

Khan Z, Farman A. The prosthodontist′s role in head and neck cancer and Introduction -Oncologic dentistry. J Indian Prosthodont Soc. 2006;6 (1):4. https://doi.org/10.4103/0972-4052.25874

Mclaren RJ, Mclaren O, Hardman J, GarasG, Smith ME, Ishii H et al. The role of allied healthcare professionals in head and neck cancer surveillance: A Systematic Review. Clin Otolaryngol 2020 Jan;45(1):83-98. https://doi.org/10.1111/coa.13471

Wiedenmann F, Liebermann A, Probst F, Troeltzsch M, Balermpas P, Guckenberg M, A pattern of Care Analysis: Prosthetic Rehabilitation of Head and Neck Cancer Patients after Radiotherapy. Clinical implant dentistry and related research.2020; 22(3): 333-341. https://doi.org/10.1111/cid.12912

Byers RM. Factors affecting choice of initial therapy in oral cancer. Semin Surg Oncol. 1995;11(3):183-9. https://doi.org/10.1002/ssu.2980110303

Starcke EN, Shannon IL. How critical is the interval between extractions and irradiation in patients with head and neck malignancy? Oral Surg Oral Med Oral Pathol.1977;43(3):333-7. https://doi.org/10.1016/0030-4220(77)90317-6

Baba NZ. Maxillofacial Rehabilitation: Prosthodontic and Surgical Management of Cancer-Related, Acquired, and Congenital Defects of the Head and Neck, 3rd Revised edition. 2013;22 (3): 250. https://doi.org/10.1111/jopr.12041

Carini F, Pisapia V, Monai D, Barbano L, Porcaro G.Implant rehabilitation in patients irradiated for head and neck cancer: role of Intensity-Moduled Radiotherapy (IMRT) in planning the insertion site. Ann Stomatol (Roma). 2012;3(2 Suppl):8-20

Starcke EN, Shannon IL. How critical is the interval between extractions and irradiation in patients with head and neck malignancy?. Oral Surg Oral Med Oral Pathol. 1977;43(3):333-7. https://doi.org/10.1016/0030-4220(77)90317-6

Beumer J, Marunick MT, Esposito S. Maxillofacial Rehabilitation: Prosthodontic and Surgical Management of Cancer-Related, Acquired, and Congenital Defects of the Head and Neck, 3rd Revised edition. Hanover Park, IL: Quintessence Publishing Co Inc, U.S; September 12, 2011.

Carini F, Pisapia V, Monai D, Barbano L, Gianluca P. Implant rehabilitation in patients irradiated for head and neck cancer: role of Intensity-Moduled Radiotherapy (IMRT) in planning the insertion siteAnn Stomatol (Roma). 2012;3(2 Suppl):8-20.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2021 El Hawari W et al.

Downloads

Download data is not yet available.